A thiosemicarbazone derivative as a potential multi-target inhibitor: Molecular docking, DFT, QTAIM, and NLO investigation of thione and thiol tautomers
Talanta · 2027
DOI: 10.1016/j.talanta.2026.130508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Talanta, 2027. Verfasst von Nadia Benhalima und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemistry: Synthesis Properties and Applications (LCSPA), Faculty of Sciences and Technology, University of Saida, Algeria; Higher Nati…. Hauptthemen laut MEDLINE: Thiosemicarbazones, Thiones, Sulfhydryl Compounds. Die Arbeit nennt 94 Literaturangaben. Gefördert von: King Khalid University.
Abstract (Originalsprache)
Thiosemicarbazones have been widely used due to their various biological activities and interesting NLO behavior. In this study, the thione and thiol tautomers of [(E)-1-[4-[(2,4-dihydroxyphenyl) diazenyl] phenyl] ethylideneamino] thiourea have been studied at the DFT level of theory using BVP86/6-311G(d,p), coupled with molecular docking against tyrosinase, BRAF, and MEK1. The thione tautomer displayed a smaller HOMO-LUMO gap (1.780 eV), greater electrophilicity (9.52 eV), and enhanced NLO characteristics (static β = 134.525 × 10-30 esu, dynamic β = 3192.119 × 10-30 esu), along with enhanced binding affinity towards TYRP1 (-8.1 kcal/mol), and inhibitory activity against BRAF (Kᵢ = 0.214 μM), and MEK1 (Kᵢ = 0.497 μM). Based on these results, it is evident that the thione tautomer is a suitable candidate for development as a dual-inhibitor of the tyrosinase/kinase pathways, which can be used for melanoma treatment and also for optoelectronic applications. This work provides the link between theoretical predictions and experimental drug design and forms the basis for future syntheses of thiosemicarbazone-based drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Chemistry: Synthesis Properties and Applications (LCSPA), Faculty of Sciences and Technology, University of Saida, Algeria; Higher National School of Saida, Algeria.
- Laboratory of Chemistry: Synthesis Properties and Applications (LCSPA), Faculty of Sciences and Technology, University of Saida, Algeria.
- Laboratory of Technology and Solid Properties (LTPS), Faculty of Sciences and Technology, University of Mostaganem, Algeria; Faculty of Sciences and Technology, University of Mascara, Algeria.
- Division of Clinical Biochemistry, Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, 23890, Saudi Arabia. Electronic address: ersindi@uj.edu.sa.
- Department of Chemistry, Faculty of Science, King Khalid University, Abha, 61413, Saudi Arabia. Electronic address: sanabm2@hotmail.fr.
- Department of Chemistry, Faculty of Science, King Khalid University, Abha, 61413, Saudi Arabia. Electronic address: ayalzahrani@kku.edu.sa.
Förderung
- King Khalid University
Zitieren
APA
Benhalima, N., Yahia Cherif, F., Khelloul, N., Sindi, E. R., Moussa, S. B., Alzahrani, A. Y. A., Khelifaoui, A., Uddin, M. B., Abdelkrim, G., & Zaki, M. E. A. (2027). A thiosemicarbazone derivative as a potential multi-target inhibitor: Molecular docking, DFT, QTAIM, and NLO investigation of thione and thiol tautomers. Talanta. https://doi.org/10.1016/j.talanta.2026.130508
Vancouver
Benhalima N, Yahia Cherif F, Khelloul N, Sindi ER, Moussa SB, Alzahrani AYA, et al. A thiosemicarbazone derivative as a potential multi-target inhibitor: Molecular docking, DFT, QTAIM, and NLO investigation of thione and thiol tautomers. Talanta. 2027. doi:10.1016/j.talanta.2026.130508
BibTeX
@article{Benhalima2027,
author = {Benhalima, Nadia and Yahia Cherif, Fatima and Khelloul, Nawel and Sindi, Emad Rashad and Moussa, Sana Ben and Alzahrani, Abdullah Yahya Abdullah and Khelifaoui, Ahmed and Uddin, Mohammad Borhan and Abdelkrim, Guendouzi and Zaki, Magdi E A},
title = {A thiosemicarbazone derivative as a potential multi-target inhibitor: Molecular docking, DFT, QTAIM, and NLO investigation of thione and thiol tautomers},
journal = {Talanta},
year = {2027},
doi = {10.1016/j.talanta.2026.130508}
}
EUVIMED